BioXcel Therapeutics Inc (NASDAQ:BTAI) shares are trading higher. The AI biopharmaceutical company on Monday announced positive meeting comments from the U.S. Food and Drug Administration (FDA).
BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What’s Going On?
view original post